According to Business Quant data, insiders at BioRestorative Therapies reported 84.74K shares in total in their latest Form 4 filings, or 18.85% of the 449.66K shares outstanding; that total is unchanged from 84.74K shares (split-adjusted) at the end of Q2 2026 and up 1.88% from 83.18K shares (split-adjusted) at the end of Q3 2025.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Dale Broadrick | TenPercentOwner | 22,297 | 0 | 22,297 | 46.0% | 04 Nov, 2024 |
| 2 | Francisco Silva | Vp Of Research And Development | 16,357 | 0 | 16,357 | 33.8% | 17 Oct, 2025 |
| 3 | Lance Alstodt | President, Ceo, Cob | 9,375 | 0 | 9,375 | 19.4% | 17 Oct, 2025 |
| 4 | Robert Eugene Kristal | Chief Financial Officer | 400 | 0 | 400 | 0.8% | 15 Jun, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $32.00 | $375.01K | 8,569 | Direct |
| 06 Oct, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 15,625 | $32.00 | $500.00K | 9,375 | Direct |
| 06 Oct, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 11,719 | $0.00 | $0 | 586 | Direct |
| 06 Oct, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 11,719 | $0.00 | $0 | 586 | Direct |
| 14 Feb, 2025 | Nickolay V. Kukekov | Director | Acquired A | 52,632 | $0.00 | $0 | 2,632 | Direct |
| 14 Feb, 2025 | Patrick F. Williams | Director | Acquired A | 52,632 | $0.00 | $0 | 2,632 | Direct |
| 14 Feb, 2025 | David A Rosa | Director | Acquired A | 52,632 | $0.00 | $0 | 2,632 | Direct |
| 14 Feb, 2025 | Robert Eugene Kristal | Chief Financial Officer | Acquired A | 166,492 | $0.00 | $0 | 8,325 | Direct |
| 14 Feb, 2025 | Lance Alstodt | President, Ceo, Cob | Acquired A | 791,885 | $0.00 | $0 | 39,594 | Direct |
| 14 Feb, 2025 | Francisco Silva | Vp Of Research And Development | Acquired A | 768,979 | $0.00 | $0 | 38,449 | Direct |
| 28 Oct, 2024 | Dale Broadrick | TenPercentOwner | Disposed S | 1,112 | $31.60 | $35.14K | 22,297 | Direct |
| 08 Apr, 2024 | Francisco Silva | Vp Of Research And Development | Acquired P | 476 | $22.60 | $10.76K | 7,396 | Direct |
| 08 Apr, 2024 | Francisco Silva | Vp Of Research And Development | Acquired P | 1,232 | $23.40 | $28.83K | 7,458 | Direct |
| 09 Apr, 2024 | Francisco Silva | Vp Of Research And Development | Acquired P | 6,600 | $25.00 | $165.00K | 7,788 | Direct |
| 18 Mar, 2024 | Lance Alstodt | President, Ceo, Cob | Disposed F | 17,633 | $27.80 | $490.20K | 8,594 | Direct |
| 18 Mar, 2024 | Francisco Silva | Vp Of Research And Development | Disposed F | 17,193 | $27.80 | $477.97K | 7,373 | Direct |
| 13 Feb, 2024 | David A Rosa | Director | Acquired A | 79,646 | $0.00 | $0 | 3,982 | Direct |
| 13 Feb, 2024 | Nickolay V. Kukekov | Director | Acquired A | 79,646 | $0.00 | $0 | 3,982 | Direct |
| 13 Feb, 2024 | Robert Paccasassi | Vp, Qa And Reg Compliance | Acquired A | 219,298 | $0.00 | $0 | 10,965 | Direct |
| 13 Feb, 2024 | Patrick F. Williams | Director | Acquired A | 79,646 | $0.00 | $0 | 3,982 | Direct |